On the current management of osteosarcoma. A critical evaluation and a proposal for a modified treatment strategy

This publication has 52 references indexed in Scilit:

• Impact of scheduling on toxicity and clinical efficacy of doxorubicin: What do we know in the mid-nineties?
  European Journal Of Cancer, 1996
• Targeted Radiotherapy of Osteosarcoma Using¹⁵³Sm-Edtmp: A new promising approach
  Acta Oncologica, 1996
• Extremity and Non-Extremity High-Grade Osteosarcoma: The Norwegian Radium Hospital experience during the modern chemotherapy era
  Acta Oncologica, 1996
• Immunoscintigraphy of bone sarcomas—results in 5 patients
  European Journal Of Cancer, 1994
• Survival, prognosis, and therapeutic response in osteogenic sarcoma. The memorial hospital experience
  Cancer, 1992
• Influence of Doxorubicin Dose Intensity on Response and Outcome for Patients With Osteogenic Sarcoma and Ewing's Sarcoma
  JNCI Journal of the National Cancer Institute, 1991
• Adriamycin-methotrexate high dose versus adriamycin-methotrexate moderate dose as adjuvant chemotherapy for osteosarcoma of the extremities: a randomized study
  European Journal of Cancer and Clinical Oncology, 1986
• The Effect of Adjuvant Chemotherapy on Relapse-Free Survival in Patients with Osteosarcoma of the Extremity
  New England Journal of Medicine, 1986
• The Will Rogers Phenomenon
  New England Journal of Medicine, 1985
• Favorable response of metastatic osteogenic sarcoma to pulse high-dose methotrexate with citrovorum rescue and radiation therapy
  Cancer, 1973